Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteosarcoma | 10 | 2021 | 898 | 1.770 |
Why?
|
| Bone Neoplasms | 7 | 2020 | 2532 | 0.640 |
Why?
|
| Dogs | 14 | 2021 | 3838 | 0.600 |
Why?
|
| E2F Transcription Factors | 1 | 2015 | 269 | 0.490 |
Why?
|
| Retinoblastoma Protein | 1 | 2015 | 671 | 0.390 |
Why?
|
| Immunity, Cellular | 1 | 2017 | 1558 | 0.390 |
Why?
|
| Hemangiosarcoma | 3 | 2019 | 218 | 0.320 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2017 | 8491 | 0.280 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 11908 | 0.190 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 7595 | 0.190 |
Why?
|
| Gene Expression Profiling | 6 | 2020 | 9374 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2019 | 70 | 0.170 |
Why?
|
| Neoplasm Metastasis | 3 | 2017 | 4883 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2019 | 698 | 0.130 |
Why?
|
| Stromal Cells | 2 | 2021 | 1327 | 0.130 |
Why?
|
| Cell Line, Tumor | 6 | 2021 | 16871 | 0.120 |
Why?
|
| Mice, Nude | 2 | 2021 | 3605 | 0.120 |
Why?
|
| Jurkat Cells | 1 | 2015 | 736 | 0.110 |
Why?
|
| Prognosis | 5 | 2021 | 29561 | 0.100 |
Why?
|
| Arginase | 1 | 2013 | 80 | 0.100 |
Why?
|
| Tumor Microenvironment | 2 | 2016 | 3810 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2013 | 286 | 0.100 |
Why?
|
| Fas Ligand Protein | 1 | 2012 | 215 | 0.100 |
Why?
|
| Cyclin B2 | 1 | 2011 | 5 | 0.100 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2019 | 2925 | 0.100 |
Why?
|
| Interleukin-8 | 1 | 2014 | 698 | 0.090 |
Why?
|
| Animals | 14 | 2021 | 167838 | 0.090 |
Why?
|
| Vimentin | 1 | 2011 | 255 | 0.090 |
Why?
|
| Arginine | 1 | 2013 | 934 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 3584 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 3774 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2020 | 12774 | 0.060 |
Why?
|
| Neoplasm Transplantation | 2 | 2021 | 2015 | 0.060 |
Why?
|
| Neovascularization, Pathologic | 2 | 2014 | 2635 | 0.060 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 1930 | 0.060 |
Why?
|
| Cluster Analysis | 1 | 2011 | 2698 | 0.060 |
Why?
|
| Cell Proliferation | 2 | 2016 | 10440 | 0.060 |
Why?
|
| Survival Rate | 1 | 2017 | 12800 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 6532 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 18110 | 0.040 |
Why?
|
| Apoptosis | 2 | 2013 | 9492 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2017 | 21988 | 0.040 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2019 | 76 | 0.040 |
Why?
|
| Mice | 4 | 2021 | 81138 | 0.040 |
Why?
|
| Viscera | 1 | 2019 | 138 | 0.040 |
Why?
|
| RNA Stability | 1 | 2020 | 336 | 0.040 |
Why?
|
| Exosomes | 1 | 2021 | 423 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2013 | 3797 | 0.030 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 894 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2020 | 915 | 0.030 |
Why?
|
| Semaphorins | 1 | 2015 | 97 | 0.030 |
Why?
|
| Epigenomics | 1 | 2020 | 935 | 0.030 |
Why?
|
| Receptors, Interleukin-8 | 1 | 2014 | 1 | 0.030 |
Why?
|
| Genomics | 2 | 2020 | 5775 | 0.030 |
Why?
|
| Exons | 1 | 2020 | 2389 | 0.030 |
Why?
|
| Blood Vessels | 1 | 2019 | 1112 | 0.030 |
Why?
|
| Cell Survival | 2 | 2014 | 5796 | 0.030 |
Why?
|
| Humans | 9 | 2021 | 759255 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 2015 | 652 | 0.030 |
Why?
|
| DNA Transposable Elements | 1 | 2015 | 752 | 0.020 |
Why?
|
| Genome | 1 | 2019 | 1739 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2015 | 705 | 0.020 |
Why?
|
| Female | 5 | 2021 | 390240 | 0.020 |
Why?
|
| Culture Media | 1 | 2013 | 899 | 0.020 |
Why?
|
| Adult Stem Cells | 1 | 2013 | 221 | 0.020 |
Why?
|
| Breast | 1 | 2019 | 1979 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 13621 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2015 | 1114 | 0.020 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2010 | 307 | 0.020 |
Why?
|
| DNA Primers | 1 | 2013 | 2817 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2011 | 41247 | 0.020 |
Why?
|
| Necrosis | 1 | 2012 | 1613 | 0.020 |
Why?
|
| Computational Biology | 1 | 2020 | 3505 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 3615 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 11058 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2020 | 4371 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 6131 | 0.020 |
Why?
|
| Cell Line | 1 | 2020 | 15636 | 0.020 |
Why?
|
| ras Proteins | 1 | 2010 | 1051 | 0.020 |
Why?
|
| Leukemia | 1 | 2013 | 1511 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2013 | 2939 | 0.010 |
Why?
|
| Lymphoma | 1 | 2013 | 1898 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 9528 | 0.010 |
Why?
|
| Base Sequence | 1 | 2013 | 12450 | 0.010 |
Why?
|
| Mutation | 2 | 2019 | 29877 | 0.010 |
Why?
|
| Calcium | 1 | 2014 | 5721 | 0.010 |
Why?
|
| Gene Expression | 1 | 2013 | 7593 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2013 | 10185 | 0.010 |
Why?
|
| Male | 3 | 2014 | 358719 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 17750 | 0.010 |
Why?
|
| Inflammation | 1 | 2010 | 10747 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 23362 | 0.010 |
Why?
|
Concepts
(92)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_